What this query usually means
This query usually comes from someone who is already experiencing a treatment trade-off rather than merely researching BPH in general.
Finasteride changes DHT signaling rather than simply relaxing the bladder outlet. That difference explains why many finasteride questions are about months rather than days, prostate size rather than immediate flow, and PSA interpretation rather than only symptom scores.
Different alternatives create different sexual trade-offs
Tamsulosin and silodosin are more associated with ejaculation changes; tadalafil can improve erectile function but has cardiovascular interaction considerations; other 5-alpha-reductase inhibitors share class-related sexual adverse effects; and procedures vary widely in ejaculatory outcomes.
Clinical interpretation should stay anchored to the reason finasteride was prescribed. A symptom, laboratory change or lack of benefit can mean different things depending on prostate size, treatment duration, adherence, other medicines and the original treatment goal.
How to turn this into a useful treatment discussion
Define which sexual outcome matters most before switching. Libido, erection quality, ejaculation volume, orgasm and fertility concerns are different endpoints.
Bring the prescriber a concise timeline: when treatment started, which symptoms changed, which did not, any sexual or breast-related symptoms, recent PSA values, and whether doses were missed. That is much more actionable than a vague statement that the medicine “isn’t working.”
What the major sources support
NIDDK lists finasteride and dutasteride among 5-alpha-reductase inhibitors used for BPH because they can stop prostate growth or shrink the prostate. U.S. prescribing information documents effects on PSA and sexual adverse reactions. The AUA guideline places 5-alpha-reductase inhibitors within a broader decision framework that considers prostate enlargement, symptom burden and progression risk.
Questions to discuss with your clinician
- What was the main reason finasteride was chosen for me: prostate size, progression risk, urinary symptoms, or a combination?
- How long should we give this treatment before deciding whether the benefit is adequate?
- How should my PSA be interpreted while I am taking finasteride, and what change would trigger further evaluation?
- If side effects or persistent symptoms are a problem, which alternatives preserve the benefits I still need?
Frequently asked questions
Will switching to another alpha blocker guarantee normal sexual function?
No. Alpha blockers differ in adverse-event profiles, and some are notably associated with ejaculation changes.
Could tadalafil be discussed if ED and BPH coexist?
Yes. Tadalafil is used for both conditions, but it is not suitable for everyone and has important interactions, especially with nitrates.
Does dutasteride avoid finasteride sexual side effects?
Not necessarily. Dutasteride is in the same 5-alpha-reductase inhibitor class and can also cause sexual adverse effects.
Should the drug be stopped before speaking with the prescriber?
No. If symptoms are tolerable, discuss the trade-off before changing treatment so PSA, prostate-size and symptom goals are not disrupted without a plan.
Should I stop finasteride if I think I have a side effect?
Do not stop a prescription medication solely on the basis of an online article. Contact the prescriber to review severity, timing, other possible causes and reasonable alternatives.
Can finasteride and tamsulosin be used together?
They can be prescribed together in selected men because they work differently. Whether combination therapy makes sense depends on prostate size, symptom burden, progression risk and tolerance.
Does finasteride shrink the prostate?
Finasteride is used in BPH partly because 5-alpha-reductase inhibition can reduce prostate growth and shrink enlarged prostate tissue over time.
Is finasteride appropriate for every man with BPH symptoms?
No. Treatment choice depends on symptom burden, prostate size, PSA, other conditions, current medicines, side-effect priorities and patient preferences.
Does finasteride treat prostate cancer?
Finasteride is not a treatment for prostate cancer. Because it changes PSA levels, prostate-cancer screening and PSA trends require appropriate clinical interpretation.
What should I tell my clinician before a PSA test?
Tell the clinician that you take finasteride, how long you have taken it and whether you have missed doses or recently stopped, because this can affect interpretation.
Can online symptom scores tell me which prescription drug to use?
No. They can help organize questions, but prescription selection requires clinical evaluation and should account for examination findings, medication history and other health factors.
When do urinary symptoms need urgent medical care?
Seek prompt care for inability to urinate, severe lower abdominal pain, fever with urinary symptoms, visible blood in urine, fainting or other severe symptoms.
Sources
Realvigor prioritizes U.S. prescribing information, public-health references and clinical guidelines. Source links open in a new tab.
Related finasteride decisions
Finasteride guide
Core BPH medication hub for mechanism, PSA effects, side effects and related decisions.
Tamsulosin vs Finasteride
Compare a fast symptom-relief alpha blocker with a prostate-shrinking 5-alpha-reductase inhibitor.
Finasteride sexual side effects
Review erectile, libido and ejaculation concerns with source-based context.
PSA while taking finasteride
Understand why PSA interpretation changes during finasteride treatment.
Finasteride not working
Research timeline, prostate size, symptom pattern and next questions when benefit seems limited.
Finasteride alternatives
Compare other medication classes and procedure pathways.